Regeneron Pharmaceuticals, Inc. (REGN) Financial Metrics
This dashboard provides comprehensive financial metrics and analysis to help evaluate Regeneron Pharmaceuticals, Inc.'s investment potential. View key valuation ratios, profitability metrics, growth indicators, and historical trends to make informed investment decisions.
Investment Score:
88/100
Excellent
Valuation Metrics
P/E Ratio
17.42
Strong
WeakModerateStrong
P/B Ratio
2.62
Weak
WeakModerateStrong
Earnings Yield
5.74%
Strong
WeakModerateStrong
Profitability Health
Return on Equity
15.03%
Strong
WeakModerateStrong
Operating Margin
29.39%
Strong
WeakModerateStrong
Net Profit Margin
31.07%
Strong
WeakModerateStrong
Growth Indicators
Revenue Growth
8.27%
Moderate
WeakModerateStrong
Net Income Growth
11.61%
Moderate
WeakModerateStrong
EPS Growth
10.39%
Moderate
WeakModerateStrong
Efficiency & Liquidity
Current Ratio
4.73
Strong
WeakModerateStrong
Quick Ratio
3.95
Strong
WeakModerateStrong
Asset Turnover
0.38x
Weak
WeakModerateStrong
Inventory Turnover
0.79x
Weak
WeakModerateStrong